nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0967	0.457	CbGbCtD
Frovatriptan—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0773	0.365	CbGbCtD
Frovatriptan—HTR1D—meninx—peripheral nervous system neoplasm	0.0531	0.2	CbGeAlD
Frovatriptan—HTR1B—dura mater—peripheral nervous system neoplasm	0.0505	0.19	CbGeAlD
Frovatriptan—HTR1D—dura mater—peripheral nervous system neoplasm	0.0489	0.184	CbGeAlD
Frovatriptan—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0378	0.179	CbGbCtD
Frovatriptan—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0217	0.0817	CbGeAlD
Frovatriptan—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.021	0.0791	CbGeAlD
Frovatriptan—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.0155	0.0582	CbGeAlD
Frovatriptan—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.015	0.0564	CbGeAlD
Frovatriptan—HTR1B—ganglion—peripheral nervous system neoplasm	0.00783	0.0295	CbGeAlD
Frovatriptan—HTR1D—ganglion—peripheral nervous system neoplasm	0.00758	0.0285	CbGeAlD
Frovatriptan—HTR1A—ganglion—peripheral nervous system neoplasm	0.00632	0.0238	CbGeAlD
Frovatriptan—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00385	0.0145	CbGeAlD
Frovatriptan—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00372	0.014	CbGeAlD
Frovatriptan—HTR1B—brainstem—peripheral nervous system neoplasm	0.0034	0.0128	CbGeAlD
Frovatriptan—HTR1D—brainstem—peripheral nervous system neoplasm	0.0033	0.0124	CbGeAlD
Frovatriptan—HTR1A—brainstem—peripheral nervous system neoplasm	0.00275	0.0103	CbGeAlD
Frovatriptan—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00135	0.00509	CbGeAlD
Frovatriptan—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000446	0.000854	CcSEcCtD
Frovatriptan—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000446	0.000853	CcSEcCtD
Frovatriptan—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.000851	CcSEcCtD
Frovatriptan—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000443	0.000847	CcSEcCtD
Frovatriptan—Malaise—Etoposide—peripheral nervous system neoplasm	0.000441	0.000844	CcSEcCtD
Frovatriptan—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000441	0.000844	CcSEcCtD
Frovatriptan—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000844	CcSEcCtD
Frovatriptan—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00044	0.000841	CcSEcCtD
Frovatriptan—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.000837	CcSEcCtD
Frovatriptan—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000437	0.000837	CcSEcCtD
Frovatriptan—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000837	CcSEcCtD
Frovatriptan—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000436	0.000835	CcSEcCtD
Frovatriptan—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000436	0.000835	CcSEcCtD
Frovatriptan—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000436	0.000834	CcSEcCtD
Frovatriptan—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000433	0.000828	CcSEcCtD
Frovatriptan—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000826	CcSEcCtD
Frovatriptan—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000826	CcSEcCtD
Frovatriptan—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00043	0.000823	CcSEcCtD
Frovatriptan—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000429	0.000821	CcSEcCtD
Frovatriptan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000429	0.000821	CcSEcCtD
Frovatriptan—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000428	0.00082	CcSEcCtD
Frovatriptan—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00082	CcSEcCtD
Frovatriptan—Headache—Topotecan—peripheral nervous system neoplasm	0.000426	0.000816	CcSEcCtD
Frovatriptan—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000425	0.000814	CcSEcCtD
Frovatriptan—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000425	0.000813	CcSEcCtD
Frovatriptan—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000424	0.000811	CcSEcCtD
Frovatriptan—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000424	0.000811	CcSEcCtD
Frovatriptan—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000423	0.000811	CcSEcCtD
Frovatriptan—Headache—Tretinoin—peripheral nervous system neoplasm	0.000423	0.000809	CcSEcCtD
Frovatriptan—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.000809	CcSEcCtD
Frovatriptan—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.000807	CcSEcCtD
Frovatriptan—Pain—Vincristine—peripheral nervous system neoplasm	0.000421	0.000807	CcSEcCtD
Frovatriptan—Constipation—Vincristine—peripheral nervous system neoplasm	0.000421	0.000807	CcSEcCtD
Frovatriptan—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000807	CcSEcCtD
Frovatriptan—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000807	CcSEcCtD
Frovatriptan—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000421	0.000806	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000418	0.000801	CcSEcCtD
Frovatriptan—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000416	0.000797	CcSEcCtD
Frovatriptan—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000415	0.000795	CcSEcCtD
Frovatriptan—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000794	CcSEcCtD
Frovatriptan—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000794	CcSEcCtD
Frovatriptan—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000411	0.000788	CcSEcCtD
Frovatriptan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000406	0.000778	CcSEcCtD
Frovatriptan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000404	0.000774	CcSEcCtD
Frovatriptan—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000404	0.000774	CcSEcCtD
Frovatriptan—Nausea—Topotecan—peripheral nervous system neoplasm	0.000404	0.000774	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000403	0.000771	CcSEcCtD
Frovatriptan—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000403	0.000771	CcSEcCtD
Frovatriptan—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000769	CcSEcCtD
Frovatriptan—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000401	0.000767	CcSEcCtD
Frovatriptan—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000401	0.000767	CcSEcCtD
Frovatriptan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000399	0.000764	CcSEcCtD
Frovatriptan—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000764	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000397	0.00076	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000758	CcSEcCtD
Frovatriptan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000396	0.000758	CcSEcCtD
Frovatriptan—Nausea—Melphalan—peripheral nervous system neoplasm	0.000396	0.000757	CcSEcCtD
Frovatriptan—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000753	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.00075	CcSEcCtD
Frovatriptan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000391	0.000749	CcSEcCtD
Frovatriptan—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00039	0.000746	CcSEcCtD
Frovatriptan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00039	0.000746	CcSEcCtD
Frovatriptan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00039	0.000746	CcSEcCtD
Frovatriptan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000389	0.000744	CcSEcCtD
Frovatriptan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000386	0.000739	CcSEcCtD
Frovatriptan—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000381	0.000728	CcSEcCtD
Frovatriptan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000379	0.000725	CcSEcCtD
Frovatriptan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000377	0.000722	CcSEcCtD
Frovatriptan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000377	0.000721	CcSEcCtD
Frovatriptan—Pain—Cisplatin—peripheral nervous system neoplasm	0.000373	0.000713	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000711	CcSEcCtD
Frovatriptan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.000702	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000697	CcSEcCtD
Frovatriptan—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000696	CcSEcCtD
Frovatriptan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000363	0.000695	CcSEcCtD
Frovatriptan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000362	0.000693	CcSEcCtD
Frovatriptan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000687	CcSEcCtD
Frovatriptan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000358	0.000686	CcSEcCtD
Frovatriptan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000356	0.000681	CcSEcCtD
Frovatriptan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000355	0.000679	CcSEcCtD
Frovatriptan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000354	0.000677	CcSEcCtD
Frovatriptan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000351	0.000671	CcSEcCtD
Frovatriptan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00035	0.00067	CcSEcCtD
Frovatriptan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000347	0.000664	CcSEcCtD
Frovatriptan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000344	0.000659	CcSEcCtD
Frovatriptan—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000344	0.000659	CcSEcCtD
Frovatriptan—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000655	CcSEcCtD
Frovatriptan—Pain—Etoposide—peripheral nervous system neoplasm	0.000341	0.000654	CcSEcCtD
Frovatriptan—Constipation—Etoposide—peripheral nervous system neoplasm	0.000341	0.000654	CcSEcCtD
Frovatriptan—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000653	CcSEcCtD
Frovatriptan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.000647	CcSEcCtD
Frovatriptan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000337	0.000646	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000644	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000634	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000329	0.00063	CcSEcCtD
Frovatriptan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000329	0.00063	CcSEcCtD
Frovatriptan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000328	0.000627	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000326	0.000625	CcSEcCtD
Frovatriptan—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000326	0.000624	CcSEcCtD
Frovatriptan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.000623	CcSEcCtD
Frovatriptan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000321	0.000615	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000614	CcSEcCtD
Frovatriptan—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00032	0.000613	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000606	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000606	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000605	CcSEcCtD
Frovatriptan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000316	0.000604	CcSEcCtD
Frovatriptan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000316	0.000604	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000604	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000603	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000313	0.0006	CcSEcCtD
Frovatriptan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000313	0.0006	CcSEcCtD
Frovatriptan—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000313	0.000599	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000598	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000595	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000591	CcSEcCtD
Frovatriptan—Headache—Vincristine—peripheral nervous system neoplasm	0.000309	0.000591	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000586	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000583	CcSEcCtD
Frovatriptan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.000582	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000581	CcSEcCtD
Frovatriptan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000298	0.000571	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000568	CcSEcCtD
Frovatriptan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000294	0.000563	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000562	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000561	CcSEcCtD
Frovatriptan—Nausea—Vincristine—peripheral nervous system neoplasm	0.000293	0.00056	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00056	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000559	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000558	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000555	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000554	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000551	CcSEcCtD
Frovatriptan—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000286	0.000548	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000547	CcSEcCtD
Frovatriptan—Chills—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000541	CcSEcCtD
Frovatriptan—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000282	0.000541	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000539	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000538	CcSEcCtD
Frovatriptan—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000277	0.00053	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000528	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000525	CcSEcCtD
Frovatriptan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000273	0.000523	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.00052	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000518	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000517	CcSEcCtD
Frovatriptan—Tension—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000515	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000514	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00051	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000508	CcSEcCtD
Frovatriptan—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000264	0.000505	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000505	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000501	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000498	CcSEcCtD
Frovatriptan—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000259	0.000496	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000489	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000487	CcSEcCtD
Frovatriptan—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000254	0.000486	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000486	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000482	CcSEcCtD
Frovatriptan—Headache—Etoposide—peripheral nervous system neoplasm	0.00025	0.000479	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000479	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000477	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000476	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000473	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000472	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000472	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000471	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00047	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000467	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000464	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000461	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000455	CcSEcCtD
Frovatriptan—Nausea—Etoposide—peripheral nervous system neoplasm	0.000237	0.000454	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000451	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000447	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000447	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000447	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000446	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000445	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000442	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000438	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000437	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000436	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000436	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000432	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000429	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000428	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000427	CcSEcCtD
Frovatriptan—Shock—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000421	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000421	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000418	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000414	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000413	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000413	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000413	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000412	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000409	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000408	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000404	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.0004	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000396	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00039	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00039	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000387	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000387	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000385	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000383	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000382	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000381	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000378	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000377	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000372	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000369	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000366	CcSEcCtD
Frovatriptan—Pain—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000366	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000361	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000359	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000356	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000353	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000353	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000352	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00035	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000349	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000345	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000342	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000339	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000339	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000339	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000339	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000327	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000324	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000316	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000313	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000313	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000307	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000303	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000293	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000292	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000284	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000283	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00028	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000272	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000271	CcSEcCtD
Frovatriptan—Headache—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000268	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000262	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000254	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000252	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000248	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000235	CcSEcCtD
